Literature DB >> 24636995

Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat.

Julie K Jadlowsky1, Julian Y Wong, Amy C Graham, Curtis Dobrowolski, Renee L Devor, Mark D Adams, Koh Fujinaga, Jonathan Karn.   

Abstract

The role of the negative elongation factor (NELF) in maintaining HIV latency was investigated following small hairpin RNA (shRNA) knockdown of the NELF-E subunit, a condition that induced high levels of proviral transcription in latently infected Jurkat T cells. Chromatin immunoprecipitation (ChIP) assays showed that latent proviruses accumulate RNA polymerase II (RNAP II) on the 5' long terminal repeat (LTR) but not on the 3' LTR. NELF colocalizes with RNAP II, and its level increases following proviral induction. RNAP II pause sites on the HIV provirus were mapped to high resolution by ChIP with high-throughput sequencing (ChIP-Seq). Like cellular promoters, RNAP II accumulates at around position +30, but HIV also shows additional pausing at +90, which is immediately downstream of a transactivation response (TAR) element and other distal sites on the HIV LTR. Following NELF-E knockdown or tumor necrosis factor alpha (TNF-α) stimulation, promoter-proximal RNAP II levels increase up to 3-fold, and there is a dramatic increase in RNAP II levels within the HIV genome. These data support a kinetic model for proviral transcription based on continuous replacement of paused RNAP II during both latency and productive transcription. In contrast to most cellular genes, HIV is highly activated by the combined effects of NELF-E depletion and activation of initiation by TNF-α, suggesting that opportunities exist to selectively activate latent HIV proviruses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24636995      PMCID: PMC4019061          DOI: 10.1128/MCB.01013-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  98 in total

1.  Negative elongation factor (NELF) coordinates RNA polymerase II pausing, premature termination, and chromatin remodeling to regulate HIV transcription.

Authors:  Malini Natarajan; Gillian M Schiralli Lester; Chanhyo Lee; Anamika Missra; Gregory A Wasserman; Martin Steffen; David S Gilmour; Andrew J Henderson
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

2.  Pausing of RNA polymerase II disrupts DNA-specified nucleosome organization to enable precise gene regulation.

Authors:  Daniel A Gilchrist; Gilberto Dos Santos; David C Fargo; Bin Xie; Yuan Gao; Leping Li; Karen Adelman
Journal:  Cell       Date:  2010-11-12       Impact factor: 41.582

3.  Chromatin reassembly factors are involved in transcriptional interference promoting HIV latency.

Authors:  Edurne Gallastegui; Gonzalo Millán-Zambrano; Jean-Michel Terme; Sebastián Chávez; Albert Jordan
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

4.  Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2.

Authors:  Julia Friedman; Won-Kyung Cho; Chung K Chu; Kara S Keedy; Nancie M Archin; David M Margolis; Jonathan Karn
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

5.  Functional association of Gdown1 with RNA polymerase II poised on human genes.

Authors:  Bo Cheng; Tiandao Li; Peter B Rahl; Todd E Adamson; Nicholas B Loudas; Jiannan Guo; Katayoun Varzavand; Jeffrey J Cooper; Xiaopeng Hu; Averell Gnatt; Richard A Young; David H Price
Journal:  Mol Cell       Date:  2012-01-13       Impact factor: 17.970

6.  T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway.

Authors:  Young Kyeung Kim; Uri Mbonye; Joseph Hokello; Jonathan Karn
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

7.  SR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymerase.

Authors:  Xiong Ji; Yu Zhou; Shatakshi Pandit; Jie Huang; Hairi Li; Charles Y Lin; Rui Xiao; Christopher B Burge; Xiang-Dong Fu
Journal:  Cell       Date:  2013-05-09       Impact factor: 41.582

8.  Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency.

Authors:  Haleh Rafati; Maribel Parra; Shweta Hakre; Yuri Moshkin; Eric Verdin; Tokameh Mahmoudi
Journal:  PLoS Biol       Date:  2011-11-29       Impact factor: 8.029

9.  HIV latency and integration site placement in five cell-based models.

Authors:  Scott Sherrill-Mix; Mary K Lewinski; Marylinda Famiglietti; Alberto Bosque; Nirav Malani; Karen E Ocwieja; Charles C Berry; David Looney; Liang Shan; Luis M Agosto; Matthew J Pace; Robert F Siliciano; Una O'Doherty; John Guatelli; Vicente Planelles; Frederic D Bushman
Journal:  Retrovirology       Date:  2013-08-16       Impact factor: 4.602

10.  The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat.

Authors:  Ursula Schulze-Gahmen; Heather Upton; Andrew Birnberg; Katherine Bao; Seemay Chou; Nevan J Krogan; Qiang Zhou; Tom Alber
Journal:  Elife       Date:  2013-03-05       Impact factor: 8.140

View more
  54 in total

1.  RNAP II processivity is a limiting step for HIV-1 transcription independent of orientation to and activity of endogenous neighboring promoters.

Authors:  Katarzyna Kaczmarek Michaels; Frank Wolschendorf; Gillian M Schiralli Lester; Malini Natarajan; Olaf Kutsch; Andrew J Henderson
Journal:  Virology       Date:  2015-09-14       Impact factor: 3.616

Review 2.  Molecular mechanisms of HIV latency.

Authors:  Daniele C Cary; Koh Fujinaga; B Matija Peterlin
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

3.  Phosphorylation of HEXIM1 at Tyr271 and Tyr274 Promotes Release of P-TEFb from the 7SK snRNP Complex and Enhances Proviral HIV Gene Expression.

Authors:  Uri R Mbonye; Benlian Wang; Giridharan Gokulrangan; Mark R Chance; Jonathan Karn
Journal:  Proteomics       Date:  2015-05-15       Impact factor: 3.984

Review 4.  Barriers for HIV Cure: The Latent Reservoir.

Authors:  Sergio Castro-Gonzalez; Marta Colomer-Lluch; Ruth Serra-Moreno
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-28       Impact factor: 2.205

Review 5.  Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.

Authors:  Uri Mbonye; Jonathan Karn
Journal:  Virology       Date:  2014-02-22       Impact factor: 3.616

6.  Sulfonation pathway inhibitors block reactivation of latent HIV-1.

Authors:  Jeffrey P Murry; Joseph Godoy; Amey Mukim; Justine Swann; James W Bruce; Paul Ahlquist; Alberto Bosque; Vicente Planelles; Celsa A Spina; John A T Young
Journal:  Virology       Date:  2014-10-11       Impact factor: 3.616

7.  Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1+ and TIGIT+ CD4 T Cells.

Authors:  George N Llewellyn; Eduardo Seclén; Stephen Wietgrefe; Siyu Liu; Morgan Chateau; Hua Pei; Katherine Perkey; Matthew D Marsden; Sarah J Hinkley; David E Paschon; Michael C Holmes; Jerome A Zack; Stan G Louie; Ashley T Haase; Paula M Cannon
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

8.  Exosomes from uninfected cells activate transcription of latent HIV-1.

Authors:  Robert A Barclay; Angela Schwab; Catherine DeMarino; Yao Akpamagbo; Benjamin Lepene; Seble Kassaye; Sergey Iordanskiy; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

9.  Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.

Authors:  Uri Mbonye; Benlian Wang; Giridharan Gokulrangan; Wuxian Shi; Sichun Yang; Jonathan Karn
Journal:  J Biol Chem       Date:  2018-05-09       Impact factor: 5.157

Review 10.  The effects of cocaine on HIV transcription.

Authors:  Mudit Tyagi; Jaime Weber; Michael Bukrinsky; Gary L Simon
Journal:  J Neurovirol       Date:  2015-11-16       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.